DC Field | Value | Language |
dc.contributor.author | Cernova, Natalia | |
dc.contributor.author | Diug, Eugen | |
dc.contributor.author | Ciobanu, Nicolae | |
dc.contributor.author | Guranda, Diana | |
dc.contributor.author | Ciobanu, Cristina | |
dc.contributor.author | Solonari, Rodica | |
dc.date.accessioned | 2020-11-09T12:39:18Z | |
dc.date.available | 2020-11-09T12:39:18Z | |
dc.date.issued | 2020-10 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/12724 | |
dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | |
dc.description | Department of Drug Technology, Faculty of Pharmacy, Nicolae Testemitanu SUMPh, Chisinau, Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
dc.description.abstract | Introduction. Vectorized drugs release into the colon is
required for the local treatment of
various diseases. The purpose of a
vectorized delivery system consists in
protection of the active substance from
the action of gastric and intestinal juice
and to release the drug to the site of
action. Purpose. Study of the literature in order to
highlight the types of systems and
excipients susceptible to colon delivery. Material and methods. Bibliographic study of international
medical and pharmaceutical journals in
electronic databases (PubMed and
Hinari), on specific transport systems in
the colon and the excipients used in their
formulation. Results. Due to its high water absorption capacity, the
content of the colon are considerably viscous,
the more than 400 species of bacteria cause
various reactions such as azoreduction and
enzymatic cleavage, and they are responsible
for the metabolism of many drugs. The
transport of drugs in the colon (fig.1) can be
done using different systems, processes and
formulation excipients: pH-dependent
polymers (6.6-7.0); delayed release systems
(after 5-6 hours); microbiologically
biodegradable polymers; enzymatically
hydrolyzable drug precursors; azopolymers;
polysaccharide (chitosan); osmotic systems
with controlled release (fig.2) (OROS-CT, push
pull). Conclusions. The formulation of therapeutic systems with
the use of new excipients, allows the
localization of the action in the colon, thus
contributing to the optimization of
pharmacotherapy in this segment of
gastrointestinal tract. | en_US |
dc.language.iso | other | en_US |
dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" | en_US |
dc.subject | colon | en_US |
dc.subject | treatment | en_US |
dc.subject | vector release | en_US |
dc.subject | formulation | en_US |
dc.title | Formulation of colon vectorized medicines | en_US |
dc.type | Other | en_US |
Appears in Collections: | Culegere de postere
|